NEW YORK, NY -- (MARKET WIRE) -- March 05, 2007 -- A study entitled "Does Blood Volume and BNP Correlate?" was presented at the annual Critical Care Conference in Orlando. Daxor's (AMEX: DXR) BVA-100 was used for the study. The senior authors were Susan M. Apte, Mihae Yu, et al. from Queen's Hospital, Hawaii, the largest hospital in the Hawaiian Islands. B-type natriuretic peptide (BNP) is a cardiac neurohormone predominantly released from the ventricles in response to stretch of ventricular myocytes or increases in wall tension. BNP is widely used for diagnosing the presence of heart failure. Values of BNP have been used to guide physicians in determining fluid and diuretic therapy for patients with cardiac dysfunction. The BNP test is manufactured by Biosite. The Biosite Company makes no claim that BNP is a measure of the blood volume status of the patient. However, many physicians use BNP levels as a guide to administering or withholding fluids from patients in heart failure.
